Purchase Order 75N95022P00084
Award Date
1/12/22
Potential Completion Date
1/11/23
Potential Value
$202K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NIH NCATS) awarded a $122,612.40 firm fixed-price purchase order to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, for 14 Mouse ON-TARGET plus small interfering RNA (siRNA) libraries. This non-competitive, brand-name acquisition was conducted under simplified acquisition procedures without any small business set-aside. The purchase...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $30,316.20 firm fixed price purchase order to Horizon Discovery Biosciences Limited, located in Great Britain, United Kingdom. The contract is for unspecified products or services to be delivered between July 12, 2023 and July 22, 2023 in support of NIH's efforts to enhance the development, testing, and implementation of translational sciences. Horizon...
Horizon Discovery Biosciences LIMITED has been awarded a firm fixed price purchase order totaling one hundred twenty-one thousand two hundred ninety-four dollars and sixty-four cents ($121,294.64) by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to supply a Dharmacon Human On-TargetPlus Druggable Genome siRNA Library for the Functional Genomic Lab. The purchase order does not include any set-aside designations...
The Department of Health and Human Services' National Institutes of Health's National Center for Advancing Translational Sciences awarded a $13,474 purchase order to Horizon Discovery Biosciences Limited of Great Britain. Under the firm fixed price contract, Horizon Discovery will provide ON-TARGETPLUS MOUSE AAK1 small interfering RNA SMARTPOOL consisting of 50 nanomoles of the described product. Place of performance will be Great Britain, with work occurring between September 5 and November...
This $14,810.64 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Horizon Discovery Biosciences LIMITED, a foreign-owned, for-profit manufacturer of genetic research materials. The award is for the supply of Horizon Discovery's SMARTVECTOR human whole genome lentiviral shRNA pooled library and associated USB plate map files. This specialized genetic...
This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Horizon Discovery LIMITED, a UK-based for-profit biotechnology company. The $30,805.00 contract is for genome editing testing services, with an ultimate completion date of December 31, 2015. The contract does not have a set-aside designation....
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $12,235.00 firm-fixed-price purchase order contract to Horizon Discovery Limited, a for-profit biotechnology company based in the United Kingdom. The contract is for the provision of custom human cell lines to support biomedical research, with a completion date of December 13, 2019. No set-aside was used for this award. Horizon Discovery...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), to Horizon Discovery Limited, a UK-based biotechnology company, for whole-genome CRISPR knockout gene interaction screening services. The contract, valued at $92,500, was awarded in support of NICHD research to translate genomic and genetic research into a greater understanding of human genetic disease and the...
Dharmacon, Inc., a foreign-owned for-profit organization, received a $16,148.76 firm-fixed-price purchase order contract from the Department of Health and Human Services' National Institutes of Health, National Center for Advancing Translational Sciences. The contract is for the delivery of a Mimic library, which includes custom RNA interference reagents, genome libraries, and other products to support the agency's scientific research programs. This contract is not set aside for any specific...
Dharmacon, Inc., a foreign-owned for-profit corporation, was awarded a $11,316 fixed-price purchase order contract by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences. The contract is for the provision of custom RNA interference (RNAi) small interfering RNA (siRNA) plates to support scientific research programs. No set-aside designation was used. Dharmacon is a supplier of various scientific research products and...